Subscribe to RSS
DOI: 10.1055/s-0041-1726756
Clinical performance of an ultra-long axial field of view PET/CT: a head-to-head comparison with a regular digital PET/CT
Ziel/Aim To establish the performance of the new ultra-long axial field-of-view (UL-FOV) Siemens Biograph Vision Quadra and a regular (R-FOV) digital Siemens Biograph Vision 600 PET/CT system in an intra-patient comparison.
Methodik/Methods 20 patients underwent oncological PET/CT following a single administration of 3.5 MBq/kg 18F-FDG. 10 patients received scans first on a R-FOV system (axial FOV 26.3 cm) at 60 min p.i. in continuous bed motion (1.1 mm/s, equivalent to 2 min/bed position) and then on an UL-FOV system (axial FOV 106 cm) with one bed position (“vertex to thighs”) and a total acquisition of 10 minutes in list-mode. A subsequent 10 patients were then examined with the same parameters, with the first examination on the UL-FOV and the second exam on the R-FOV system.
Ergebnisse/Results Interim analysis revealed equivalent image quality for the 1 min/bp UL-FOV with the R-FOV images. At 1.1 mm/s table velocity, the R-FOV would require a 19.4 min examination time to achieve equivalent anatomical coverage and image quality comparable to 1 min acquisitions on the UL-FOV. Likewise, equivalence in image quality with the R-FOV system is obtained with reduction in 90 % in exposure, which would result in a mean equivalent dose of 0.4 mSv for the PET. Although of lower quality compared to the R-FOV images, 15s/bp acquisitions on the UL-FOV scanner were sufficient to afford an appreciation of all pathological lesions.
Schlussfolgerungen/Conclusions Image quality obtained on an UL-FOV scanner were of substantially higher quality for equivalent total examination time. Protocols for the UL-FOV scanner which deliver equivalent image quality to a state-of-the art digital R-FOV scanner could include either shorter effective scan times (1 min versus 19.4 min to obtain equivalent anatomical coverage and quality) or could be achieved with significant reduction in dose (90 %). Ultra-fast or ultra-low dose scans can be considered in selected cases.
#
Publication History
Article published online:
08 April 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany